BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16075892)

  • 21. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
    Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
    Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
    Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
    Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
    Oppezzo P; Dighiero G
    Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
    Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
    Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
    Schettino EW; Cerutti A; Chiorazzi N; Casali P
    J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.
    Stamatopoulos K; Belessi C; Hadzidimitriou A; Smilevska T; Kalagiakou E; Hatzi K; Stavroyianni N; Athanasiadou A; Tsompanakou A; Papadaki T; Kokkini G; Paterakis G; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A
    Blood; 2005 Nov; 106(10):3575-83. PubMed ID: 16076869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
    Ritgen M; Lange A; Stilgenbauer S; Dohner H; Bretscher C; Bosse H; Stuhr A; Kneba M; Dreger P
    Blood; 2003 Mar; 101(5):2049-53. PubMed ID: 12411304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
    Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
    Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.
    Murray F; Darzentas N; Hadzidimitriou A; Tobin G; Boudjogra M; Scielzo C; Laoutaris N; Karlsson K; Baran-Marzsak F; Tsaftaris A; Moreno C; Anagnostopoulos A; Caligaris-Cappio F; Vaur D; Ouzounis C; Belessi C; Ghia P; Davi F; Rosenquist R; Stamatopoulos K
    Blood; 2008 Feb; 111(3):1524-33. PubMed ID: 17959859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.
    Matolcsy A; Casali P; Nádor RG; Liu YF; Knowles DM
    Blood; 1997 Mar; 89(5):1732-9. PubMed ID: 9057657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
    Marasca R; Maffei R; Morselli M; Zucchini P; Castelli I; Martinelli S; Fontana M; Ravanetti S; Curotti M; Leonardi G; Cagossi K; Partesotti G; Torelli G
    J Mol Diagn; 2005 Nov; 7(5):566-74. PubMed ID: 16258154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
    Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.
    Galligan L; Catherwood MA; Matthews C; Morris TC; Alexander HD
    Leuk Lymphoma; 2008 Apr; 49(4):763-8. PubMed ID: 18398745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
    Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R
    Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia.
    Sahota SS; Davis Z; Hamblin TJ; Stevenson FK
    Blood; 2000 Jun; 95(11):3534-40. PubMed ID: 10828040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.